On Friday, March 9, Atlantic Trading USA LLC (Atlantic) filed a class action complaint in Chicago federal court against numerous unnamed trading firms, alleging manipulation of the Chicago Board Options Volatility Index (VIX). Atlantic alleges that, from 2011 to the present, trading firms have manipulated the VIX settlement price by placing aggressive buy orders during the HOSS auction and then taking advantage of the artificially high VIX settlement price to cash out of expiring long VIX derivatives at a profit. Atlantic claims to represent a nationwide class of investors that has traded VIX futures or options since 2011 and seeks damages “in the hundreds of millions of dollars.” The case is captioned Atlantic Trading USA LLC. V. John Does 1-100, 18-cv-01754 (N.D.Ill.), and the complaint can be found here.
Similar class action complaints were recently filed in New York federal court, alleging collusive and manipulative VIX trading in violation of the Sherman and Clayton Acts, respectively. Those cases are captioned Samuel v. John Does 1-100, 18-cv-01593-AT (S.D.N.Y.) and David Quint v. DRW Holdings and John Does, 18-cv-01980-AT.
Plaintiffs in these cases are serving subpoenas on the Chicago Board Options Exchange and the Chicago Futures Exchange to obtain information sufficient to identify the firms involved in the trading activity at issue. We expect this process to take at least one month and, more likely, it will probably require several months. In the meantime, as a protective measure, trading firms should consider retaining, in addition to their routine account statements and order flow records, any other records reflecting HOSS order imbalances and the firm’s own objective risk and value assessments that formed the basis for their trading decisions during this time.
Steve Bedell, Katie Trkla, Tom Krebs, and Ellen Wheeler have represented numerous clients in numerous VIX-related regulatory proceedings and have defended regulators’ allegations of VIX manipulation arising from SPX order activity in the HOSS on VIX settlement day − an issue central to these lawsuits. For more about our team and our experience in this area, please contact us via our information below, or visit Foley.com.
Similar class action complaints were recently filed in New York federal court, alleging collusive and manipulative VIX trading in violation of the Sherman and Clayton Acts, respectively. Those cases are captioned Samuel v. John Does 1-100, 18-cv-01593-AT (S.D.N.Y.) and David Quint v. DRW Holdings and John Does, 18-cv-01980-AT.
Plaintiffs in these cases are serving subpoenas on the Chicago Board Options Exchange and the Chicago Futures Exchange to obtain information sufficient to identify the firms involved in the trading activity at issue. We expect this process to take at least one month and, more likely, it will probably require several months. In the meantime, as a protective measure, trading firms should consider retaining, in addition to their routine account statements and order flow records, any other records reflecting HOSS order imbalances and the firm’s own objective risk and value assessments that formed the basis for their trading decisions during this time.
Steve Bedell, Katie Trkla, Tom Krebs, and Ellen Wheeler have represented numerous clients in numerous VIX-related regulatory proceedings and have defended regulators’ allegations of VIX manipulation arising from SPX order activity in the HOSS on VIX settlement day − an issue central to these lawsuits. For more about our team and our experience in this area, please contact us via our information below, or visit Foley.com.
Author(s)
Related Insights
April 28, 2026
Health Care Law Today
Medicare Payment Suspensions Emerge as a Key Tool in Federal Anti-Fraud Efforts — Focus on California Hospices
Medicare payment suspensions result in a cessation of payments for Medicare services until the suspension is resolved, typically several months after the initial action to suspend. Payments withheld will then be released after recoupment of any determined overpayments. The Trump Administration has stated that it will aggressively use its authority (created by the 2010 Affordable Care Act) to suspend payments based upon a credible allegation of fraud. Below we set forth the context for such suspensions, as well as the key parameters for such actions.
April 28, 2026
Health Care Law Today
Psychedelics and the Executive Order: From Schedule I to Treatment Priority
On April 18, 2026, President Donald Trump signed an executive order titled Accelerating Medical Treatments for Serious Mental Illness, directing federal agencies to expedite the research, review, and approval of psychedelic drugs as potential treatments for serious mental health conditions. The Order represents a significant federal policy shift aimed at addressing what the Trump Administration describes as a crisis of serious mental illness in America, with particular emphasis on patients whose conditions have not responded to standard therapies.
April 27, 2026
Labor & Employment Law Perspectives
The Elusive PAGA Early Evaluation Conference
According to the PAGA reform statute, employers with at least 100 employees can seek an Early Evaluation Conference within the time required to respond to the lawsuit to allow a neutral evaluator to decide a wide range of issues,